Close Menu

Davita Agrees to Settle Whistleblower Lawsuit For $55 Million

Despite denying any wrongdoing, Denver-based Davita Inc., a kidney dialysis chain, has settled a Texas lawsuit related to its use of Epogen, an anemic drug made by Amgen. The settlement requires Davita to pay $55 million. The federal government will receive more than 70% of the settlement amount. In addition, Davita is also required to pay attorney fees.

The Texas lawsuit was brought by whistleblower, Ivey Woodard, a former Amgen employee. The lawsuit alleged that Davita defrauded the government when it used more Epogen than was medically necessary, and double billed Medicare for Epogen that was left over and later reused. Ivey Woodard argued that by using more Epogen than necessary, Davita was boosting its profits.

In addition to the Texas lawsuit, DaVita faces similar legal action in other states.
As for the whistleblower’s reward, Ivey Woodard will likely receive a share of the settlement.

If you have any firsthand knowledge, information, or evidence related to any federal, state, county or city government fraud, you should speak with an experienced qui tam lawyer who can help you understand your legal rights and help you obtain the compensation you deserve.

If you have a claim, contact the Florida whistleblower attorneys at McCabe Rabin, P.A. for a free and confidential consultation by calling toll free at 877.915.4040 or e-mail kelly@mccaberabin.com.

Facebook Twitter LinkedIn Google Plus